ERBB2 and lung adenocarcinoma: Alterations in the human epidermal growth factor receptor 2 (HER2) gene, including mutations and amplifications, have been detected in some cases of lung adenocarcinoma and shown to be associated with aggressive tumor behavior and poor prognosis (3).